As drug prices continue to climb and novel therapies challenge traditional pricing models, there is increased momentum behind value-based care and value-based reimbursement.
In this rapidly evolving climate, value assessments have become an essential component to the successful introduction of any new or innovative treatment. But what are the key drivers of the value conversation?
Adapted from his popular webinar, Precision Xtract scientific advisor and Harvard professor Dr. Anupam Jena explores how the definition of value goes beyond quality and cost of care to include other important dimensions that should be factored into developing accurate value frameworks.
This new white paper will help you:
- Learn about important components of value that traditional cost-effectiveness methods miss
- Understand approaches to address affordability challenges posed by high-cost but valuable treatments
- Identify practical steps that can promote use of the highest value treatments while reducing spending on low-value services
Start developing your value assessment strategy immediately. Download this free, informative white paper from Precision Xtract and Dr. Jena today.